Saturday 17 October 2026 Export EHC’s income statement to Excel — free account

Encompass Health Corporation

Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024. In the quarter to June 2026, revenue grew 9.58%, EPS grew 9.93%, free cash flow fell 45.0% and total debt rose 7.09%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five, operating cash flow growth for three.

127.87 0.10 +0.08%

Follow EHC

Alert me

Market cap: $12.6B
P/E: 20.6×
Fwd P/E: 16.8×
Dividend yield: 0.61%
F-score: 7/9
Altman Z: 3.25
Beneish M: −2.71
Dividend safety: 77/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 47.79

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	2	1	—	2	—	—	5	—	—

Insider Ownership 1.16%

Capital & Financial Ratios $m

Market Cap 12,600.00

Revenue 6,206.10

Net Income 833.30

Free Cash Flow 413.40

Net Debt 2,500.50

Current Ratio 1.19

Debt/Equity 0.77

P/E ratio 20.56

Fwd P/E 16.80

P/S ratio 2.04

P/B ratio 3.71

Past 5Y EPS Growth 14.22%

This Y EPS Growth 12.14%

Next Y EPS Growth 9.27%

Next Y revenue growth 8.84%

Next 5Y EPS Growth 10.18%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 69.70%

10-year low 10-year high

P/S against its own 10 years 95.80%

10-year low 10-year high

P/B against its own 10 years 91.37%

10-year low 10-year high

EV/Sales against its own 10 years 90.38%

10-year low 10-year high

EV/FCF against its own 10 years 63.32%

10-year low 10-year high

Dividends

Payout Ratio 0.13

Annual Dividend Rate 0.78

Annual Dividend Yield 0.61%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	0.78	0.19 0.19 0.19 0.21
2025	0.70	0.17 0.17 0.17 0.19
2024	0.47	0.15 0.15 0.17
2023	0.60	0.15 0.15 0.15 0.15
2022	0.80	0.22 0.28 0.15 0.15
2021	0.89	0.22 0.22 0.22 0.22
2020	0.89	0.22 0.22 0.22 0.22
2019	0.88	0.21 0.21 0.22 0.22
2018	0.83	0.20 0.20 0.21 0.21
2017	0.78	0.19 0.19 0.20 0.20
2016	0.75	0.18 0.18 0.19 0.19

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	104	123	103	134
Receivables	612	599	619	687
Inventory	—	—	—	—
Other	92	123	130	220
	842	887	906	1,041

	2023	2024	2025	Q'26
Payables	170	171	178	222
ST’ Debt	25	139	44	36
Other	212	246	290	—
	656	841	836	873

Compound Annual Growth %

	10y	5y	3y
Sales	6.66%	10.72%	10.92%
Cash Flow	8.88%	10.78%	18.54%
Earnings	12.05%	14.78%	27.84%
Book Value	15.23%	10.31%	20.78%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	1,587	1,597	—	—	—
’25	1,455	1,458	1,478	1,545	5,935
’24	1,316	1,301	1,351	1,405	5,373
’23	1,160	1,187	1,207	1,247	4,801
’22	1,059	1,063	1,090	1,137	4,349
’21	1,230	1,288	1,011	486	4,015
’20	1,182	1,074	1,174	136	3,566

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	313	283	—	—	—
’25	289	270	271	346	1,176
’24	239	217	268	279	1,003
’23	228	207	215	201	851
’22	219	245	70	172	706
’21	159	256	178	124	716
’20	29	222	173	280	705

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	151	62	—	—	—
’25	126	113	84	117	439
’24	99	61	120	80	360
’23	128	85	66	(11)	268
’22	106	132	(79)	(47)	112
’21	60	132	74	(102)	164
’20	(54)	135	83	137	300

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	1.93	1.54	—	—	—
’25	1.48	1.39	1.24	1.43	5.54
’24	1.10	1.12	1.06	1.18	4.46
’23	0.87	0.90	0.84	0.86	3.47
’22	0.87	0.49	0.45	0.89	2.70
’21	1.07	1.13	1.00	0.91	4.11
’20	0.87	0.34	0.78	0.86	2.85

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	24.07	30.42	39.12	45.14	38.19	44.80	42.19	51.15	65.99	87.85	Analyst estimates 2026–2028 Powerpack
	High	34.51	40.10	65.60	58.03	69.30	71.34	59.91	72.06	104.55	127.99
People
People	Employees	27,968	29,370	30,060	31,570	43,000	43,400	35,000	38,000	40,000	42,000
	Revenue/emp, $m	0.13	0.13	0.14	0.15	0.08	0.09	0.12	0.13	0.13	0.14
Income, $m
Income, $m	Revenue	3,643	3,914	4,277	4,605	3,566	4,015	4,349	4,801	5,373	5,935
	Gross margin, %	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
	EBT	482	496	493	562	353	505	451	607	750	953
	EBT margin, %	13.23	12.68	11.53	12.21	9.90	12.58	10.37	12.65	13.95	16.06
	Net income	318	350	375	446	369	517	366	463	597	759
	Depreciation	186	193	204	223	210	227	253	283	309	338
Per share, $
Per share, $	Revenue	40.88	41.77	43.69	46.99	36.17	40.55	43.84	48.25	53.79	59.06
	Earnings	2.77	2.73	2.98	3.65	2.87	4.15	2.72	3.51	4.53	5.62
	Cash flow	7.19	7.03	7.79	6.48	7.15	7.23	7.11	8.55	10.04	11.70
	Capex	(2.01)	(2.65)	(2.82)	(4.12)	(4.10)	(5.58)	(5.99)	(5.86)	(6.43)	(7.33)
	Free cash flow	5.18	4.37	4.97	2.36	3.04	1.65	1.13	2.69	3.61	4.37
	Book value	10.42	14.89	15.90	17.28	19.98	23.81	18.41	22.67	27.96	32.01
	Shares, m	89	94	98	98	99	99	99	100	100	101
Valuation, ×
Valuation, ×	P/E	11.95	14.92	16.53	15.10	22.92	12.51	21.94	19.13	20.30	18.85
	P/S	0.81	0.98	1.12	1.17	1.82	1.28	1.36	1.39	1.72	1.80
	P/B	3.17	2.75	3.09	3.19	3.29	2.18	3.23	2.96	3.30	3.32
	EV/Sales	1.61	1.61	1.68	1.80	2.66	2.07	1.98	1.94	2.16	2.20
	EV/FCF	12.71	15.22	14.62	37.47	34.40	58.74	93.51	39.02	35.08	31.87
Cash, $m
Cash, $m	Operating cash flow	640	658	762	635	705	716	706	851	1,003	1,176
	Capex	(179)	(249)	(276)	(404)	(405)	(552)	(594)	(583)	(642)	(736)
	Free cash flow	461	410	486	231	300	164	112	268	360	439
Balance, $m
Balance, $m	Working capital	179	185	(10)	35	231	173	141	185	46	70
	Total debt	3,016	2,578	2,514	3,063	3,289	3,278	2,767	2,713	2,498	2,491
	Net debt	2,915	2,461	2,386	2,910	3,000	3,166	2,714	2,608	2,375	2,388
	Shareholders’ equity	929	1,395	1,557	1,693	1,970	2,357	1,826	2,255	2,793	3,218
Returns, %
Returns, %	ROA	5.33	5.68	5.82	6.37	4.54	6.19	4.34	6.00	7.21	8.31
	ROIC	10.55	10.35	9.98	9.30	6.61	7.45	8.68	9.40	10.45	11.74
	ROE	28.99	23.33	19.80	22.07	15.52	19.05	12.96	17.25	18.06	18.84

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
THC Tenet Healthcare Corporation	$22.2B	10.3×	6.4×	+14.61% (above 0%: growing)	+212.97% (above 0%: growing)	−43.88% (below 0%: shrinking)	46.78%	24.85%	Compare
EHC Encompass Health Corporation	$12.6B	20.6×	16.8×	+9.58% (above 0%: growing)	+9.93% (above 0%: growing)	−45.01% (below 0%: shrinking)	100.00%	17.85%
DVA DaVita Inc.	$12.1B	15.0×	13.1×	+5.17% (above 0%: growing)	+56.49% (above 0%: growing)	+49.36% (above 0%: growing)	32.70%	16.29%	Compare
FMS Fresenius Medical Care AG & Co. KGaA	$11.8B	11.5×	12.5×	+3.89% (above 0%: growing)	+6.82% (above 0%: growing)	+1.57% (above 0%: growing)	26.95%	9.58%	Compare
UHS Universal Health Services, Inc.	$11.0B	7.5×	6.1×	+8.27% (above 0%: growing)	+9.47% (above 0%: growing)	−23.78% (below 0%: shrinking)	90.87%	11.14%	Compare
ENSG The Ensign Group, Inc.	$10.4B	26.9×	24.1×	+17.33% (above 0%: growing)	+16.22% (above 0%: growing)	+12.24% (above 0%: growing)	16.65%	8.50%	Compare
PACS PACS Group, Inc.	$7.6B	27.6×	16.8×	+9.07% (above 0%: growing)	+45.45% (above 0%: growing)	+220.51% (above 0%: growing)	17.07%	7.66%	Compare
CHE Chemed Corporation	$6.7B	25.7×	20.4×	+8.80% (above 0%: growing)	+42.78% (above 0%: growing)	−43.51% (below 0%: shrinking)	32.90%	13.25%	Compare
CON Concentra Group Holdings Parent, Inc.	$5.0B	24.9×	17.0×	+10.03% (above 0%: growing)	+45.71% (above 0%: growing)	+91.62% (above 0%: growing)	31.70%	18.99%	Compare
Median of peers	$10.7B	19.9×	15.0×	+8.94%	+44.12%	+6.91%	32.20%	12.20%

All 55 Medical Care Facilities stocks →

Encompass Health Corporation (EHC) key facts

Strength: Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024.
Strength: Net income was $759.1 million, or $5.62 per share (basic), a net margin of 9.54%.
Encompass Health Corporation (EHC) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, EHC traded at $127.87, a market capitalization of $12.6 billion.
At that price the stock trades at 20.6× trailing-twelve-month earnings and 2.0× sales; its P/E is higher than 70% of its own readings over the past ten years.
Encompass Health Corporation pays an annual dividend of $0.78 per share, a yield of 0.61%, with a payout ratio of 12.7%.
Return on equity was 18.8% and debt-to-equity 0.77.
Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.25 (safe zone) for fiscal 2025.